Chenggong Li Yan Sun Jing Wang Lu Tang Huiwen Jiang Tao Guo Lin Liu Yaohui Wu Lisha Ai Linghui Xia Jianjun Wu Zhicai Lin Qijun Qian Yu Hu Heng Mei
10.3389/fimmu.2021.599493
Front Immunol
2021 May 25;12:599493.
piggybac transposon system chimeric antigen receptor-t cell therapy diffuse large b cell lymphoma lenalidomide maintenance relapsed/refractory triple-hit lymphoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/34113336/
Immunotherapy, Adoptive Lenalidomide / administration & dosage Lymphoma, Large B-Cell, Diffuse / therapy Remission Induction
Immunotherapy, Adoptive Lenalidomide / administration & dosage Lymphoma, Large B-Cell, Diffuse / therapy Remission Induction Case Reports Clinical Trial, Phase I Research Support, Non-U.S. Gov't Humans Lymphoma, Large B-Cell, Diffuse / immunology Lymphoma, Large B-Cell, Diffuse / pathology Male Middle Aged Recurrence Lenalidomide
PMC8186315
34113336
PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report
2021